Cite
MLA Citation
Anna Turkova et al.. “Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial.” Lancet, vol. 9, no. 9, 2022, pp. e627–e637. http://access.bl.uk/ark:/81055/vdc_100164415177.0x00000c